Date published: 
21 December 2017
Type: 
News
Intended audience: 
Health professionals

 

Date first published on the Immunise Australia website: 4 August 2015

The shingles vaccine, Zostavax®, has been approved to be placed on the National Immunisation Program (NIP), to be provided free of charge from 1 November 2016 to people aged 70 years, subject to vaccine supply. There will also be a 5 year catch-up program for people aged 71 to 79 years.

The implementation of new vaccination programs under the NIP is a major task that takes approximately 12 to 18 months from receipt of Government funding approval. This time is required for activities such as the procurement of vaccine; vaccine safety surveillance planning; development of appropriate communications; and negotiation with states and territories regarding implementation requirements and timing. In the case of the Zostavax® vaccine, time is also required to develop and roll out an adult vaccination register.

For more information about Zostavax®, refer to the zoster section of the Australian Immunisation Handbook 10th edition 2015.

For more information on herpes-zoster (shingles), refer to the shingles page.